April 14, 2018

AL NAIYEAM SERVICES LLC   is one of the Best Selling Distributor.We are Legitimate registered Corporation, based at USA, Saudi Arabia since long.

PRICE LIST
-----------------

Below is our Price List:

Apple Iphone 5 64GB -- $490USD
Apple Iphone 5 32GB -- $450USD
Apple Iphone 5 16GB -- $450USD

Apple iPad mini Wi-Fi + Cellular Unlocked 64GB
Apple iPad mini Wi-Fi + Cellular Unlocked 32GB
Apple iPad mini Wi-Fi + Cellular Unlocked 16GB

Apple Ipad 3 wifi +4G 64gb::$450usd
Apple Ipad 3 wifi +4G 32gb::$400usd
Apple Ipad 3 wifi +4G 16gb::$390usd

Apple Iphone 4S 16GB
Apple Iphone 4s 32GB
Apple Iphone 4s 64GB

Samsung GT-I9300 Galaxy SIII -- $450usd
Samsung galaxy note 2 N7100 -- $450usd
Samsung GT-N8000 Galaxy Note -- $480usd
Samsung SGH-I317 Galaxy Note II 16GB -- $470usd
Samsung Galaxy Note II 16GB SGH-T889 -- $480usd
Samsung i9100 Galaxy SII --$350usd
Samsung galaxy note n7000 --$370usd
Samsung Galaxy Premier I9260
Samsung Galaxy Stratosphere II I415
Samsung Galaxy S Duos S7562
Samsung Series 7 Slate PC --$490usd
Samsung i9250 Google Galaxy Nexus 4G 32GB--$350usd
Samsung Nexus S I9023 White--$340usd

Blackberry Z10 -- $650usd
Blackberry Tk Victory with Special Pin
BlackBerry Porsche Design P9981-- $450usd
Blackberry Blade --- $380usd
BlackBerry BOLD Torch 9900 --- $350usd
Blackberry storm 5--- $350usd
Blackberry 9930-- $380usd
BlackBerry Bold 9790
BlackBerry Torch 2 9810 --$370usd
BLACKBERRY Torch 9860 ---- $350usd
BLACKBERRY Torch 9850 ---- $350usd
BlackBerry Style 9670 --- $350usd

PRODUCTS

PRODUCTS

  March 28, 2018

Products

Pharmaceuticals Division – a strong player on the Chinese health care market

The Pharmaceuticals Division focuses on prescription drugs for the therapeutic areas of cardiology, oncology, gynecology, hematology and ophthalmology. With its innovative pharmaceutical products, Bayer seeks to achieve a significant therapeutic benefit for patients while at the same time satisfying the growing requirements of physicians and health insurers. The Pharmaceuticals division in China is headquartered in Beijing with facilities in Beijing, Guangzhou, Chengdu and Jiangsu.

Bayer constructed a pharmaceutical production and packaging facility in Beijing from 1995 to 1997, manufacturing solid and semisolid products. To meet the growing needs of the Chinese market, the company invested significantly in the expansion of the company’s Beijing site. The site increased its production capacity several times following the expansion and was equipped with state-of-the-art technology, including the fastest packaging line in both China and the whole Asia-pacific area. In 2011, the Beijing site received the “Good Manufacturing Practice” certification from the Beijing Drug Administration Bureau. It was the first pharmaceutical enterprise in Beijing to receive this certification.

In anticipation of increasing product demand in China, Bayer is investing EUR 100 million to significantly increase the production capacity of its Beijing plant. The planned capacity expansion is designed to ensure a reliable supply of high-quality products to meet the Chinese market’s demand for pharmaceutical products, including the company’s cardiovascular and anti-diabetes products. The expansion will include improved logistics for fully automated material handling, analytical laboratories, and high-speed packaging lines.

The Pharmaceuticals Division’ s Radiology business is a world leader in developing and manufacturing contrast agents used in X-ray, computed tomography (CT) and magnetic resonance imaging (MRI), as well as injection systems for diagnostic and therapeutic medical procedures in CT, MRI and cardiovascular and peripheral vascular diseases.

CHINA CONDITIONALLY

CHINA CONDITIONALLY

  March 27, 2018

China conditionally approves Bayer's acquisition of Monsanto

Reuters Staff

2 MIN READ

BEIJING (Reuters) - Bayer’s (BAYGn.DE) on Tuesday secured conditional approval from China’s commerce ministry for its planned acquisition of the world No. 1 seed company Monsanto (MON.N), chalking up a victory in the onerous struggle to win over watchdogs across the globe.

FILE PHOTO: The logo of Bayer AG is pictured at the Bayer Healthcare subgroup production plant in Wuppertal, Germany February 24, 2014. REUTERS/Ina Fassbender/File Photo

The ministry also ordered the German drug and crop chemicals maker to spin off some businesses globally, including vegetable seeds, corn, soybean, cotton, and herbicide, according to a statement posted on the ministry’s website.

Bayer has already pledged to sell certain seed and herbicide assets for 5.9 billion euros ($7.27 billion) to BASF (BASFn.DE) to address EU regulatory concerns and has separately offered to sell its vegetable seeds business to BASF.